163 related articles for article (PubMed ID: 24440402)
1. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.
Abouzeid AH; Patel NR; Torchilin VP
Int J Pharm; 2014 Apr; 464(1-2):178-84. PubMed ID: 24440402
[TBL] [Abstract][Full Text] [Related]
2. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.
Abouzeid AH; Patel NR; Sarisozen C; Torchilin VP
Pharm Res; 2014 Aug; 31(8):1938-45. PubMed ID: 24522815
[TBL] [Abstract][Full Text] [Related]
3. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.
Sarisozen C; Abouzeid AH; Torchilin VP
Eur J Pharm Biopharm; 2014 Oct; 88(2):539-50. PubMed ID: 25016976
[TBL] [Abstract][Full Text] [Related]
4. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922
[TBL] [Abstract][Full Text] [Related]
5. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
[TBL] [Abstract][Full Text] [Related]
6. Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.
Zhao MD; Li JQ; Chen FY; Dong W; Wen LJ; Fei WD; Zhang X; Yang PL; Zhang XM; Zheng CH
Int J Nanomedicine; 2019; 14():9453-9467. PubMed ID: 31819443
[TBL] [Abstract][Full Text] [Related]
7. Mixed micelles of TPGS and Soluplus
Wang Y; Ding Y; Xu Y; Wang C; Ding Y; Gao M; Ma C; Ma X; Li L
Pharm Dev Technol; 2020 Sep; 25(7):865-873. PubMed ID: 32266855
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.
Cho H; Lai TC; Kwon GS
J Control Release; 2013 Feb; 166(1):1-9. PubMed ID: 23246471
[TBL] [Abstract][Full Text] [Related]
9. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
Saxena V; Hussain MD
J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
[TBL] [Abstract][Full Text] [Related]
11. Multi-drug delivery to tumor cells via micellar nanocarriers.
Katragadda U; Teng Q; Rayaprolu BM; Chandran T; Tan C
Int J Pharm; 2011 Oct; 419(1-2):281-6. PubMed ID: 21820041
[TBL] [Abstract][Full Text] [Related]
12. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.
Devalapally H; Duan Z; Seiden MV; Amiji MM
Clin Cancer Res; 2008 May; 14(10):3193-203. PubMed ID: 18483388
[TBL] [Abstract][Full Text] [Related]
13. The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles.
Zou W; Sarisozen C; Torchilin VP
J Drug Target; 2017 Mar; 25(3):225-234. PubMed ID: 27616277
[TBL] [Abstract][Full Text] [Related]
14. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
Wang J; Li Y; Wang L; Wang X; Tu P
Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
[TBL] [Abstract][Full Text] [Related]
16. Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles.
Wang Y; Fan W; Dai X; Katragadda U; Mckinley D; Teng Q; Tan C
Mol Pharm; 2014 Apr; 11(4):1140-50. PubMed ID: 24579673
[TBL] [Abstract][Full Text] [Related]
17. Polymeric nanoassemblies entrapping curcumin overcome multidrug resistance in ovarian cancer.
Gou Q; Liu L; Wang C; Wu Q; Sun L; Yang X; Xie Y; Li P; Gong C
Colloids Surf B Biointerfaces; 2015 Feb; 126():26-34. PubMed ID: 25543980
[TBL] [Abstract][Full Text] [Related]
18. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein.
Jin Y; Zhang Z; Zhao T; Liu X; Jian L
J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.
Desale SS; Cohen SM; Zhao Y; Kabanov AV; Bronich TK
J Control Release; 2013 Nov; 171(3):339-48. PubMed ID: 23665258
[TBL] [Abstract][Full Text] [Related]
20. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]